17-7673797-A-G
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_000546.6(TP53):c.823T>C(p.Cys275Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C275Y) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000546.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Li-Fraumeni syndrome 1 Pathogenic:1
This variant is considered likely pathogenic. Functional studies indicate this variant impacts protein function [PMID: 29979965]. This variant is expected to disrupt protein structure [Myriad internal data]. -
Hereditary cancer-predisposing syndrome Pathogenic:1
This missense variant replaces cysteine with arginine at codon 275 in the DNA binding domain of the TP53 protein. Computational prediction tools and conservation analyses suggest that this variant may have deleterious impact on the protein function. Different variants affecting the same position, p.Cys275Trp and p.Cys275Tyr, are considered to be disease-causing (ClinVar variation ID: 485044, 215997), suggesting that cysteine or similar amino acid at this position is important for the protein function. Multiple functional studies have shown that the mutant protein is non-functional in growth suppression, cell proliferation and transactivation assays (PMID: 12826609, 21343334, 30224644 and IARC database) and has a dominant-negative effect on growth suppression (PMID: 30224644). This variant has been observed in individuals affected with early-onset breast cancer (PMID: 31119730), acute myeloid leukemia (PMID: 32164171) and Li-Fraumeni-like syndrome (PMID: 35033608). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Different missense variants occurring at the same codon, p.Cys275Trp and p.Cys275Tyr, are thought to be disease-causing and have been observed in individuals affected with Li-Fraumeni syndrome (ClinVar variation ID: 485044, 215997), indicating that cysteine at this position is important for TP53 protein function. Based on the available evidence, this variant is classified as Likely Pathogenic. -
Li-Fraumeni syndrome Uncertain:1
This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 275 of the TP53 protein (p.Cys275Arg). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects TP53 function (PMID: 12826609, 29979965, 30224644). Advanced modeling of experimental studies (such as gene expression, population dynamics, functional pathways, and cell-cycle effects in cell culture) performed at Invitae indicates that this missense variant is expected to disrupt TP53 protein function. ClinVar contains an entry for this variant (Variation ID: 376584). This missense change has been observed in individual(s) with TP53-related conditions (PMID: 28724667, 31119730). This variant is not present in population databases (gnomAD no frequency). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at